Cargando…

Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity

Mitogen-activated protein kinase-activated protein kinase 2 (MK2 or MAPKAP-K2) is a Ser/Thr kinase from the p38 mitogen-activated protein kinase signalling pathway and plays an important role in inflammatory diseases. The crystal structure of the MK2–TEI-I01800 complex has been reported; its Gly-ric...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujino, Aiko, Fukushima, Kei, Kubota, Takaharu, Kosugi, Tomomi, Takimoto-Kamimura, Midori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795553/
https://www.ncbi.nlm.nih.gov/pubmed/24121337
http://dx.doi.org/10.1107/S0909049513020736
_version_ 1782287391826903040
author Fujino, Aiko
Fukushima, Kei
Kubota, Takaharu
Kosugi, Tomomi
Takimoto-Kamimura, Midori
author_facet Fujino, Aiko
Fukushima, Kei
Kubota, Takaharu
Kosugi, Tomomi
Takimoto-Kamimura, Midori
author_sort Fujino, Aiko
collection PubMed
description Mitogen-activated protein kinase-activated protein kinase 2 (MK2 or MAPKAP-K2) is a Ser/Thr kinase from the p38 mitogen-activated protein kinase signalling pathway and plays an important role in inflammatory diseases. The crystal structure of the MK2–TEI-I01800 complex has been reported; its Gly-rich loop was found to form an α-helix, not a β-sheet as has been observed for other Ser/Thr kinases. TEI-I01800 is 177-fold selective against MK2 compared with CDK2; in order to understand the inhibitory mechanism of TEI-I01800, the cyclin-dependent kinase 2 (CDK2) complex structure with TEI-I01800 was determined at 2.0 Å resolution. Interestingly, the Gly-rich loop of CDK2 formed a β-sheet that was different from that of MK2. In MK2, TEI-I01800 changed the secondary structure of the Gly-rich loop from a β-sheet to an α-helix by collision between Leu70 and a p-ethoxyphenyl group at the 7-position and bound to MK2. However, for CDK2, TEI-I01800 bound to CDK2 without this structural change and lost the interaction with the substituent at the 7-position. In summary, the results of this study suggest that the reason for the selectivity of TEI-I01800 is the favourable conformation of TEI-I01800 itself, making it suitable for binding to the α-form MK2.
format Online
Article
Text
id pubmed-3795553
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-37955532013-10-15 Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity Fujino, Aiko Fukushima, Kei Kubota, Takaharu Kosugi, Tomomi Takimoto-Kamimura, Midori J Synchrotron Radiat Diffraction Structural Biology Mitogen-activated protein kinase-activated protein kinase 2 (MK2 or MAPKAP-K2) is a Ser/Thr kinase from the p38 mitogen-activated protein kinase signalling pathway and plays an important role in inflammatory diseases. The crystal structure of the MK2–TEI-I01800 complex has been reported; its Gly-rich loop was found to form an α-helix, not a β-sheet as has been observed for other Ser/Thr kinases. TEI-I01800 is 177-fold selective against MK2 compared with CDK2; in order to understand the inhibitory mechanism of TEI-I01800, the cyclin-dependent kinase 2 (CDK2) complex structure with TEI-I01800 was determined at 2.0 Å resolution. Interestingly, the Gly-rich loop of CDK2 formed a β-sheet that was different from that of MK2. In MK2, TEI-I01800 changed the secondary structure of the Gly-rich loop from a β-sheet to an α-helix by collision between Leu70 and a p-ethoxyphenyl group at the 7-position and bound to MK2. However, for CDK2, TEI-I01800 bound to CDK2 without this structural change and lost the interaction with the substituent at the 7-position. In summary, the results of this study suggest that the reason for the selectivity of TEI-I01800 is the favourable conformation of TEI-I01800 itself, making it suitable for binding to the α-form MK2. International Union of Crystallography 2013-11-01 2013-09-26 /pmc/articles/PMC3795553/ /pubmed/24121337 http://dx.doi.org/10.1107/S0909049513020736 Text en © Aiko Fujino et al. 2013 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Diffraction Structural Biology
Fujino, Aiko
Fukushima, Kei
Kubota, Takaharu
Kosugi, Tomomi
Takimoto-Kamimura, Midori
Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity
title Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity
title_full Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity
title_fullStr Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity
title_full_unstemmed Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity
title_short Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity
title_sort crystal structure of human cyclin-dependent kinase-2 complex with mk2 inhibitor tei-i01800: insight into the selectivity
topic Diffraction Structural Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795553/
https://www.ncbi.nlm.nih.gov/pubmed/24121337
http://dx.doi.org/10.1107/S0909049513020736
work_keys_str_mv AT fujinoaiko crystalstructureofhumancyclindependentkinase2complexwithmk2inhibitorteii01800insightintotheselectivity
AT fukushimakei crystalstructureofhumancyclindependentkinase2complexwithmk2inhibitorteii01800insightintotheselectivity
AT kubotatakaharu crystalstructureofhumancyclindependentkinase2complexwithmk2inhibitorteii01800insightintotheselectivity
AT kosugitomomi crystalstructureofhumancyclindependentkinase2complexwithmk2inhibitorteii01800insightintotheselectivity
AT takimotokamimuramidori crystalstructureofhumancyclindependentkinase2complexwithmk2inhibitorteii01800insightintotheselectivity